News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PERRY GREGORY D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 14,414 options to buy
@ $23.29, valued at
$335.7k
|
|
| 06/02/2023 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 1,738 shares
@ $0
Disposed/sold 518 options to buy
@ $0
Disposed/sold 420 options to buy
@ $0
Disposed/sold 800 options to buy
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 16,604 options to buy
@ $18.56, valued at
$308.2k
|
|
| 02/28/2022 |
4
| PERRY GREGORY D (CFO) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 80,000 options to buy
@ $8.61, valued at
$688.8k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 01/02/2020 |
3
| PERRY GREGORY D (Director) has filed a Form 3 on Merus N.V. |
| 06/07/2019 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 21,000 options to buy
@ $5.35, valued at
$112.4k
|
|
| 03/02/2018 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 25,920 options to buy
@ $14.05, valued at
$364.2k
|
|
| 03/02/2018 |
3
| PERRY GREGORY D (Director) has filed a Form 3 on Kala Pharmaceuticals, Inc. |
| 05/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/11/2016 |
4
| PERRY GREGORY D (See Remarks) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 69,000 options to buy
@ $0
Granted 35,000 restricted stock units
@ $0 |
|
| 02/17/2016 |
4
| PERRY GREGORY D (See Remarks) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0 |
|
| 02/11/2016 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Unknown transaction of 21,417 shares
@ $8.5, valued at
$182k
Disposed/sold 417 options to buy
@ $10.37, valued at
$4.3k
Disposed/sold 5,000 options to buy
@ $9, valued at
$45k
Disposed/sold 5,000 options to buy
@ $5.79, valued at
$29k
Disposed/sold 5,000 options to buy
@ $6.17, valued at
$30.9k
Disposed/sold 5,000 options to buy
@ $6.39, valued at
$32k
Disposed/sold 5,000 options to buy
@ $8.36, valued at
$41.8k
|
|
| 01/04/2016 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Granted 1,250 shares
@ $0
Granted 5,000 options to buy
@ $8.36, valued at
$41.8k
|
|
| 10/01/2015 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Granted 1,250 shares
@ $0 |
|
| 08/06/2015 |
4
| PERRY GREGORY D (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 08/04/2015 |
4
| PERRY GREGORY D (CFO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0 |
|
| 07/02/2015 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Granted 1,250 shares
@ $0 |
|
| 04/01/2015 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Granted 1,250 shares
@ $0
Granted 1,250 shares
@ $0 |
|
| 02/27/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2015 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $6.39, valued at
$32k
|
|
| 01/02/2015 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Granted 1,250 shares
@ $0 |
|
| 10/01/2014 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on ADVANCED CELL TECHNOLOGY, INC.|
Txns:
| Granted 1,250 shares
@ $0 |
|
| 07/02/2014 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on ADVANCED CELL TECHNOLOGY, INC.|
Txns:
| Granted 125,000 shares
@ $0 |
|
|
|
|